| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.HYP.25.4.587 |
| P698 | PubMed publication ID | 7721402 |
| P2093 | author name string | J P Miller | |
| H M Perry | |||
| D W Moskowitz | |||
| G Rutan | |||
| J D Baty | |||
| J R Fornoff | |||
| M P Sambhi | |||
| S E Carmody | |||
| P2860 | cites work | Racial differences in the incidence of hypertensive end-stage renal disease (ESRD) are not entirely explained by differences in the prevalence of hypertension | Q44839105 |
| P433 | issue | 4 Pt 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| kidney disease | Q1054718 | ||
| P304 | page(s) | 587-594 | |
| P577 | publication date | 1995-04-01 | |
| P1433 | published in | Hypertension | Q5958695 |
| P1476 | title | Early predictors of 15-year end-stage renal disease in hypertensive patients | |
| P478 | volume | 25 |
| Q39121745 | A Concept-Wide Association Study of Clinical Notes to Discover New Predictors of Kidney Failure |
| Q35051169 | Adiposity patterns and the risk for ESRD in postmenopausal women |
| Q64055532 | Adrenalectomy Improves the Long-Term Risk of End-Stage Renal Disease and Mortality of Primary Aldosteronism |
| Q57591327 | Age, blood pressure and smoking effects on chronic renal failure in primary glomerular nephropathies |
| Q42614730 | Aldosterone Synthase Gene (CYP11B2) Polymorphism in Korean End-Stage Renal Disease Patients on Hemodialysis |
| Q35086974 | Applying multiple interventions in chronic kidney disease |
| Q35933646 | Association between dietary salt intake and reservation of renal function in patients with mild hypertension. |
| Q40569325 | Association of Systolic Blood Pressure Variability With Mortality, Coronary Heart Disease, Stroke, and Renal Disease |
| Q30371128 | Association of body mass index with outcomes in patients with CKD. |
| Q40311503 | Association of race, heart failure and chronic kidney disease |
| Q34460638 | Benefits from treatment and control of patients with resistant hypertension. |
| Q36309097 | Bidirectional association between ESRD dialysis and diabetes: National cohort study |
| Q38740429 | Blood Pressure Control During Chronic Kidney Disease Progression |
| Q35876466 | Blood pressure and progression of chronic kidney disease: importance of systolic, diastolic, or diurnal variation |
| Q35722933 | Blood pressure control and nephroprotection in diabetes |
| Q37593685 | Blood pressure level and kidney disease progression: do we really need to go to 130/80 mm Hg? |
| Q37085746 | Body mass index in 1.2 million adolescents and risk for end-stage renal disease |
| Q71769802 | Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy |
| Q87393470 | Chapter 4: Blood pressure management in CKD ND patients with diabetes mellitus |
| Q37261346 | Characteristics of uninsured Americans with chronic kidney disease |
| Q37967043 | Cigarette smoking and chronic kidney diseases |
| Q37165278 | Cigarette smoking: an important renal risk factor - far beyond carcinogenesis |
| Q46661747 | Cigarette smoking: an important renal risk factor – far beyond carcinogenesis. |
| Q36359500 | Clinical use and pathogenetic basis of laboratory tests for the evaluation of primary arterial hypertension |
| Q35986230 | Clinico-pathological characteristics and outcomes of patients with biopsy-proven hypertensive nephrosclerosis: a retrospective cohort study |
| Q44046719 | Comparative effects on dynamic renal potassium excretion of ACE inhibition versus angiotensin receptor blockade in hypertensive patients with type II diabetes mellitus |
| Q41514682 | Diagnostic value of urinary protein and creatinine in combination with renal ultrasound examination in early renal damage of patients with hypertension |
| Q92649522 | Dissecting the Metabolic Phenotype of the Antihypertensive Effects of Five Uncaria Species on Spontaneously Hypertensive Rats |
| Q92031308 | Dissemination and Implementation Program in Hypertension in Rwanda: Report on Initial Training and Evaluation |
| Q43599147 | Effects of calcium antagonist, benidipine, on the progression of chronic renal failure in the elderly: a 1-year follow-up |
| Q36575572 | Elevated Endothelial Hypoxia-Inducible Factor-1α Contributes to Glomerular Injury and Promotes Hypertensive Chronic Kidney Disease |
| Q33722602 | Elevated systolic blood pressure and risk of cardiovascular and renal disease: overview of evidence from observational epidemiologic studies and randomized controlled trials |
| Q28395995 | End-stage renal disease in Taiwan: a case-control study |
| Q30939425 | End-stage renal disease in young black males in a black-white population: longitudinal analysis of the Bogalusa Heart Study |
| Q53861044 | Enhanced expression of EGF receptor in a model of salt-sensitive hypertension. |
| Q37809748 | Epidemiology of hypertensive kidney disease |
| Q37982645 | Epidemiology of obesity, the metabolic syndrome, and chronic kidney disease |
| Q35553282 | Erythropoietin should be part of congestive heart failure management |
| Q46802460 | Experience with marginal living related kidney donors: are they becoming routine or are there still any doubts? |
| Q37030762 | Fixed-dose combination antihypertensives and reduction in target organ damage: are they all the same? |
| Q44397975 | Haematocrit and the risk of developing end-stage renal disease |
| Q73484534 | History of hypertension in patients treated for end-stage renal disease |
| Q36632424 | Hypertension and kidney disease: a deadly connection |
| Q46682083 | Hypertension and kidney disease: a deadly connection |
| Q50086310 | Hypertension and renal disease |
| Q35203404 | Hypertension in Cardiovascular and Kidney Disease |
| Q34028499 | Hypertension-induced organ damage in African Americans: transforming growth factor-beta(1) excess as a mechanism for increased prevalence |
| Q21994544 | Hypertensive nephrosclerosis-a cause of end-stage renal disease? |
| Q64135558 | Identifying High-Risk Individuals for Chronic Kidney Disease: Results of the CHERISH Community Demonstration Project |
| Q28344781 | Identifying and slowing progressive chronic renal failure |
| Q35075773 | Incident chronic kidney disease and newly developed complications related to renal dysfunction in an elderly population during 5 years: a community-based elderly population cohort study |
| Q40192525 | Increased body mass index is a risk factor for end-stage renal disease in the Chinese Singapore population |
| Q37243981 | Inhibition of the renin-angiotensin system and chronic kidney disease |
| Q34028532 | Is there a preferred antihypertensive therapy for isolated systolic hypertension and reduced arterial compliance? |
| Q50225845 | Lercanidipine valuable effect on urine protein losses: the RED LEVEL study |
| Q43708821 | Long-term outcomes in nondiabetic chronic kidney disease |
| Q46019200 | Longitudinal blood pressure changes and kidney function decline in persons without chronic kidney disease: Findings from the MESA study. |
| Q36109573 | Management of hypertensive chronic kidney disease: role of calcium channel blockers |
| Q35886386 | Managing high-risk patients with hypertension: focus on the renin-angiotensin system |
| Q35837912 | Microalbuminuria and sRAGE in high-risk hypertensive patients treated with nifedipine/telmisartan combination treatment: a substudy of TALENT. |
| Q34404475 | Non-interventional management of resistant hypertension |
| Q37968503 | Obstructive sleep apnea and kidney disease: is there any direct link? |
| Q35137813 | Orthostatic hypotension and incident chronic kidney disease: the atherosclerosis risk in communities study. |
| Q24607254 | Overweight, obesity, and elevated serum cystatin C levels in adults in the United States |
| Q36865845 | Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study |
| Q26782607 | Practical Approach to Detection and Management of Chronic Kidney Disease for the Primary Care Clinician |
| Q46469868 | Prevalence of microalbuminuria and its association with pulse pressure in a multi-ethnic population in Amsterdam, the Netherlands. The SUNSET Study |
| Q74741271 | Progression of diabetic nephropathy. A focus on arterial pressure level and methods of reduction |
| Q93609101 | References |
| Q44127136 | Relationship between transforming growth factor beta1 and progression of hypertensive renal disease |
| Q92078329 | Relative risk of end-stage renal disease requiring dialysis in treated ankylosing spondylitis patients compared with individuals without ankylosing spondylitis: A nationwide, population-based, matched-cohort study |
| Q36362572 | Renal protection in hypertensive patients: selection of antihypertensive therapy |
| Q33697583 | Renal surrogates in essential hypertension |
| Q33983415 | Risk factors for ESRD in individuals with preserved estimated GFR with and without albuminuria: results from the Kidney Early Evaluation Program (KEEP) |
| Q37307169 | Risk factors for end-stage renal disease: 25-year follow-up |
| Q55000179 | Serum Metabolomics Study Based on LC-MS and Antihypertensive Effect of Uncaria on Spontaneously Hypertensive Rats. |
| Q47151973 | Services aimed at achieving desirable clinical outcomes in patients with chronic kidney disease and diabetes mellitus: A narrative review. |
| Q34219071 | Slowing the progression of renal disease in diabetic patients |
| Q40753484 | Temporal relation between blood pressure and serum creatinine in young adults from a biracial community: the Bogalusa Heart Study |
| Q53776395 | The CARI guidelines. Donors at risk: obesity. |
| Q35914820 | The Envy of Scholars: Applying the Lessons of the Framingham Heart Study to the Prevention of Chronic Kidney Disease |
| Q57153967 | The United Nations High Level Meeting Addresses Noncommunicable Diseases, But Where Is Hypertension? |
| Q39198720 | The aging kidney and the nephrotoxic effects of mercury |
| Q28208693 | The cardio renal anemia syndrome: correcting anemia in patients with resistant congestive heart failure can improve both cardiac and renal function and reduce hospitalizations |
| Q41094736 | The changing face of hypertension and antihypertensive agents |
| Q43636269 | The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study |
| Q34028197 | The kidney as a target of hypertension. |
| Q34038034 | The need to lower systolic blood pressure |
| Q34281425 | The state of U.S. living kidney donors |
| Q35104626 | Therapeutic Effect of Continuous Exercise Training Program on Serum Creatinine Concentration in Men with Hypertension: A Randomized Controlled Trial |
| Q95810354 | Therapy insight: congestive heart failure, chronic kidney disease and anemia, the cardio-renal-anemia syndrome |
| Q38098108 | To RAS or not to RAS? The evidence for and cautions with renin-angiotensin system inhibition in patients with diabetic kidney disease. |
| Q35113482 | Transforming growth factor-beta 1 hyperexpression in African-American hypertensives: A novel mediator of hypertension and/or target organ damage |
| Q79749472 | [Hypertension in blacks] |
Search more.